LifeAire’s® air purification for IVF programs delivers impact where it’s needed most. Of all the variables that affect the outcome of an IVF cycle, none is as prevalent as air. And while it is accepted that clean air can help the viability of a fragile human embryo, it took LifeAire Systems’ founder Kathryn C. Worrilow, Ph.D. to reveal exactly how clean that air needs to be.
Two decades of research and testing proved that fluctuations in IVF success can be attributed to events occurring outside the laboratory. Road resurfacing, car exhaust, construction, insecticides, even cleaning products can slip through traditional air purification systems to the detriment of embryogenesis. It became clear that any real solution would have to remediate and neutralize airborne pathogens at multiple levels.
Working with a team of chemists, engineers and physicists, Dr. Worrilow developed the LifeAire system. Its proprietary, multi-staged, patented technology comprehensively addresses airborne chemical and biological pathogens. It is, quite simply, the most powerful defense a laboratory can employ, and your fastest path to a significant improvement in outcomes.
Eliminating all known airborne pathogens that can affect healthy embryogenesis, LifeAire Systems’ Aire~IVF is clinically proven to significantly improve clinical outcomes. Its patented, multi-staged molecular media and UV technologies combine to neutralize up to 99.99% of biological and chemical contaminants within source and return air—in a single pass through the system. No other system, in-room or in-duct, has the capability to continuously purify air at the levels guaranteed by LifeAire.
A clinical study using data from LifeAire Systems’ protected IVF facilities shows an average of 14.8 percentage points increase in ongoing pregnancy rates, as reported in 2014 in Fertility and Sterility. As more facilities adopt LifeAire Systems technology and report results, the latest data show an average of 19.7 percentage points increase in ongoing pregnancy rates* following system installation.
*As defined by positive fetal heartbeat per intrauterine sac. Data is inclusive of all maternal ages, 3,535 cycles and 7,733 embryos transferred.
Click here to read our article “LifeAire Systems air purification technology improves IVF success by double digits” – Cleanroom Technology, Oct 2016
Featuring Dr. Kathryn C. Worrilow, Founder & CEO, LifeAire Systems in conversation with host, Giles Palmer.
The conversation after the webinar, “Return to Cairo”, focusing on what has changed since the publication of the Cairo consensus on the IVF laboratory environment and air quality in 2017.
LifeAire Systems joins an impressive group of moderators, panelists and speakers to discuss the “Cairo Consensus” on IVF lab environmental conditions and air quality.